- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Bioverativ, a Sanofi company
Total 988 results
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Genzyme, a Sanofi CompanyCompletedFocal Segmental GlomerulosclerosisUnited States, Germany, United Kingdom, Italy
-
Genzyme, a Sanofi CompanyCompletedAcute Lymphoblastic LeukemiaJapan
-
Genzyme, a Sanofi CompanyCompletedMelanoma | Carcinoma, Renal CellUnited States
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaJapan
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-HodgkinUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedRenal ImpairmentUnited States
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-Hodgkin | Multiple MyelomaUnited States
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-Hodgkin | Multiple MyelomaCanada
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, France, Germany, Israel, Italy, Netherlands, Taiwan
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2Netherlands
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Glycogenosis 2United States
-
Genzyme, a Sanofi CompanyTerminatedOsteoporosisUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease Late-Onset | Glycogen Storage Disease Type II GSD IIUnited States
-
Genzyme, a Sanofi CompanyCompletedOsteoarthritis, KneeUnited States, Canada, France, Germany, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedSolid Tumors | Leukemia, Myelocytic, Acute, Pediatric | Leukemia, Lymphocytic, Acute, Pediatric | Leukemia, Lymphocytic, Acute, Adult | Leukemia, Myelocytic, Acute, Adult | Myelodysplastic Syndromes, AdultUnited States
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2France
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, United Kingdom, Canada, Hungary, Poland, Czech Republic
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
Sanofi Pasteur, a Sanofi CompanyRecruitingRespiratory Syncytial VirusUnited States
-
Sanofi Pasteur, a Sanofi CompanyRecruitingRSV ImmunisationUnited States, Argentina, Honduras
-
Sanofi Pasteur, a Sanofi CompanyRecruitingHealthy Volunteers | Respiratory Syncytial Virus Infection | Metapneumovirus InfectionAustralia, United States
-
Sanofi Pasteur, a Sanofi CompanyCompletedInfluenza ImmunizationUnited States, Puerto Rico
-
Sanofi Pasteur, a Sanofi CompanyActive, not recruiting
-
Sanofi Pasteur, a Sanofi CompanyCompletedHealthy Volunteers | Influenza ImmunizationUnited States
-
Sanofi Pasteur, a Sanofi CompanyActive, not recruiting
-
Sanofi Pasteur, a Sanofi CompanyTerminatedInfluenza ImmunizationUnited States, Denmark, Poland, Spain
-
Sanofi Pasteur, a Sanofi CompanyTerminatedCOVID-19United States, Australia, Brazil, Honduras
-
Sanofi Pasteur, a Sanofi CompanyCompletedHealthy Volunteers (Meningococcal Infection)United States, Puerto Rico
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyActive, not recruitingMeningococcal ImmunisationUnited States, Puerto Rico
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyActive, not recruitingCOVID-19United States, Colombia, Ghana, Honduras, India, Japan, Kenya, Mexico, Nepal, Nigeria, Sri Lanka, Uganda, Ukraine
-
Sanofi Pasteur, a Sanofi CompanySuspended
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Polio Immunisation | Haemophilus Influenzae Type B Immunisation | Rotavirus ImmunisationThailand
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussis | Whooping Cough | Tetanus | DiphtheriaUnited States, Canada
-
Sanofi Pasteur, a Sanofi CompanyCompletedTetanus Immunisation (Healthy Volunteers) | Diphtheria Immunisation (Healthy Volunteers) | Pertussis Immunisation (Healthy Volunteers)Canada
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedPertussis | Tetanus | Diphtheria | Bacterial Meningitis | PoliomyelitisJapan
-
Sanofi Pasteur, a Sanofi CompanyCompletedMeningitis | Meningococcal Infections | Meningococcal MeningitisRussian Federation
-
Sanofi Pasteur, a Sanofi CompanyCompletedDengue Fever | Dengue Haemorrhagic FeverThailand
-
Sanofi Pasteur, a Sanofi CompanyCompletedYellow Fever (Healthy Volunteers)United States